Pay per view: Report modifier -JW for discarded amounts of single-use drugs and biologicals (CAP participants excluded)
APCs Weekly Monitor, July 11, 2008
Want to receive articles like this one in your inbox? Subscribe to APCs Weekly Monitor!
Providers should report modifier -JW (?Drug or biological amount discarded/not administered to any patient?) when processing certain types of drugs to receive payment for partial use of those drugs, according to Transmittal 1478, which became effective April 14. According to the transmittal, CMS hopes the modifier will result in the most efficient possible use of biologicals and drugs. Report this modifier when a provider administers the patient portion of a biological or drug from a single-use package or a single-use vial. Modifier -JW ensures payment for the portion the patient received and the portion discarded.
Providers who participate in the Competitive Acquisition Program (CAP)?which allows CMS to select vendors who fill physician orders for drugs and other pharmaceuticals?can no longer report modifier -JW to receive reimbursement for unused vials, according to the transmittal.
Transmittal 1478 states the following:
When processing all drugs except those provided under the Competitive Acquisition Program for Part B drugs and biologicals, local contractors may require the use of the modifier -JW to identify unused drug or biologicals from single-use vials or single-use packages that are appropriately discarded.
Click here to learn when to report modifier -JW. Briefings on APCs subscribers have free access to this article in the July issue via their online subscription.
Want to receive articles like this one in your inbox? Subscribe to APCs Weekly Monitor!
Comments
0 comments on “Pay per view: Report modifier -JW for discarded amounts of single-use drugs and biologicals (CAP participants excluded) ”
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Identify potential Medicaid RAC target areas
- Topic: CMS, OESS post new security compliance review information, checklist
- HIPAA Q&A: Level of encryption needed for email
- Capturing all necessary codes for IUD insertion and removal can be challenging
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- QA:Coding multiple initial infusions
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HIPAA Q&A: Level of encryption needed for email
- Q&A: Follow CMS' coding guidelines when using modifier -25
- What does case-mix index mean to you?
- Catch up on what's new with injections and infusions
- CMS has reformulated payments for some bilateral procedures
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- ED-to-inpatient transfers are flawed with safety gaps
- Searched